Skip to content
Screener

Staar Surgical STAA Investing Cash Flow

Investing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.11B+93.9%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$139M-6.9%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$4M+653%
IAR
Integra LifeSciencesIART
-$43.28M-99.9%
Schering-Plough logo
Schering-PloughSGP
-$1.67M-916%
Glaukos logo
GlaukosGKOS
$10.5M+128%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.25B-7.5%
Enterprise value$1.16B-5.7%
P/S4.3×-1.7×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0000718937-26-000023
Line itemThree Months Ended / April 3, 2026Three Months Ended / March 28, 2025
Purchase of investments available for sale(4,519)(14,691)
Proceeds from maturity of investments available for sale5,45951,148
Proceeds from sale of investments available for sale1,650362
Net cash provided by investing activities2,14735,351
Cash flows from financing activities:
Repayment of finance lease obligations(42)
Repurchase of employee common stock for taxes withheld(1,867)(1,283)
Proceeds from the exercise of stock options170376

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Staar Surgical's investing cash flow?
Staar Surgical (STAA) reported investing cash flow of $2.15M in Q1 2026.
How has Staar Surgical's investing cash flow changed year-over-year?
Staar Surgical's investing cash flow decreased by 93.9% year-over-year, from $35.35M to $2.15M.
What is the long-term trend for Staar Surgical's investing cash flow?
Over 3 years (2021 to 2024), Staar Surgical's investing cash flow has grown at a 63.1% compound annual growth rate (CAGR), from -$13.65M to -$59.22M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Staar Surgical's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude